Avalo Therapeutics (AVTX) Cash from Investing Activities (2016 - 2026)
Avalo Therapeutics (AVTX) posted Cash from Investing Activities of -$329.93 million for Q2 2026, compared with -$70.86 million a year earlier.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Cash from Investing Activities (2016 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Investing Activities at Avalo Therapeutics was -$315.28 million; for FY2025, it was -$81.72 million.
- In prior years, Avalo Therapeutics' Cash from Investing Activities was $356,000 in FY2024, -$133,000 in FY2023, -$95,000 in FY2022 and -$113,000 in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Cash from Investing Activities in data going back to Q1 2016.
- According to Business Quant data, Cash from Investing Activities for the three prior quarters was $25.51 million (Q1 2026), $2.4 million (Q4 2025) and -$13.26 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Avalo Therapeutics | 653.59 Mn | 653.59 Mn | - | -329.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -329.93 Mn |
| Mar 31, 2026 | 25.51 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Sep 30, 2025 | -13.26 Mn |
| Jun 30, 2025 | -70.86 Mn |
| Mar 31, 2024 | 356,000.00 |
| Mar 31, 2023 | -133,000.00 |
| Sep 30, 2022 | -39,000.00 |
| Jun 30, 2022 | -56,000.00 |
| Dec 31, 2021 | -11,000.00 |
| Sep 30, 2021 | -81,000.00 |
| Mar 31, 2021 | -21,000.00 |
| Dec 31, 2020 | -391,000.00 |
| Sep 30, 2020 | -63,000.00 |
| Jun 30, 2020 | 12.84 Mn |
| Mar 31, 2020 | -1.25 Mn |
| Dec 31, 2019 | -180,991.00 |
| Sep 30, 2019 | -5,085.00 |
| Jun 30, 2019 | -90,957.00 |
| Mar 31, 2019 | -165,969.00 |
API Access
Avalo Therapeutics Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();